Effects of intravenous immunoglobulins treatment of patients with relapsing-remitting multiple sclerosis on gene expression profiles of their peripheral T-cells

被引：0
|
作者：
Pigard, N.
Kuusisto, H.
Elovaara, I.
Paalavuo, R.
Schwarz, H. P.
Reipert, B.
机构：
[1] BMT Res, Vienna, Austria
[2] Univ Tampere, Sch Med, Dept Neurol, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Tampere, Finland
[4] Baxter BioSci, Vienna, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] T cells in relapsing-remitting multiple sclerosis demonstrate diminished expression of LAG-3
    Jones, Britta E.
    Maerz, Megan D.
    Somasundaram, Ashwin
    Buckner, Jane H.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [42] Altered erythrocyte MicroRNA profiles in relapsing-remitting multiple sclerosis
    Groen, K.
    Maltby, V. E.
    Tajouri, L.
    Lea, R. A.
    Fink, L.
    Sanders, K. A.
    Scott, R. J.
    Lechner-Scott, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 582 - 582
  • [43] Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients
    Arisi, Ivan
    Malimpensa, Leonardo
    Manzini, Valeria
    Brandi, Rossella
    di Sturmeck, Tommaso Gosetti
    D'Amelio, Chiara
    Crisafulli, Sebastiano
    Ferrazzano, Gina
    Belvisi, Daniele
    Malerba, Francesca
    Florio, Rita
    Pascale, Esterina
    Soreq, Hermona
    Salvetti, Marco
    Cattaneo, Antonino
    D'Onofrio, Mara
    Conte, Antonella
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    Taskapilioglu, Ozlem
    Turan, Asli Bahar
    Albas, Murat
    Turan, Omer Faruk
    TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (01) : 17 - 20
  • [45] Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis
    Xu, L.
    Xu, Z.
    Xu, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01): : 26 - 30
  • [46] New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis
    Fox, Edward J.
    Rhoades, Robert W.
    CURRENT OPINION IN NEUROLOGY, 2012, 25 : S11 - S19
  • [47] Oral laquinimod for treatment of relapsing-remitting multiple sclerosis
    Weiner, Howard L.
    LANCET NEUROLOGY, 2008, 7 (08): : 672 - 673
  • [48] Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Ingwersen, Jens
    Aktas, Orhan
    Hartung, Hans-Peter
    NEUROTHERAPEUTICS, 2016, 13 (01) : 47 - 57
  • [49] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [50] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Vosiliou, S.
    DRUGS OF TODAY, 2010, 46 (05) : 315 - 325
12345